(ARWR) Arrowhead Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Arrowhead Pharmaceuticals | (ARWR) share price targets
Complete technical analysis of Arrowhead Pharmaceuticals (ARWR) by charts plus indicators, forecast predictions and share price targets for Arrowhead Pharmaceuticals (ARWR)
Arrowhead Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-28 View latest technical analysis
10 day averaged volume of Arrowhead Pharmaceuticals is 1209504
| Date | Daily Closing Price | Open | High | Low | Volume |
| 28 Tue May 2024 | 23.92 | 25.36 | 25.36 | 23.41 | 0.782 times |
| 23 Thu May 2024 | 24.67 | 25.19 | 25.19 | 24.37 | 0.677 times |
| 22 Wed May 2024 | 25.14 | 25.00 | 26.09 | 24.89 | 0.524 times |
| 21 Tue May 2024 | 25.02 | 24.65 | 25.27 | 24.65 | 0.432 times |
| 20 Mon May 2024 | 24.82 | 24.78 | 25.05 | 24.41 | 0.367 times |
| 17 Fri May 2024 | 24.77 | 24.95 | 25.64 | 24.57 | 0.587 times |
| 16 Thu May 2024 | 25.00 | 25.02 | 25.26 | 24.17 | 0.939 times |
| 15 Wed May 2024 | 25.04 | 23.58 | 25.22 | 23.50 | 1.07 times |
| 14 Tue May 2024 | 22.91 | 22.39 | 24.22 | 22.39 | 1.692 times |
| 13 Mon May 2024 | 22.06 | 22.34 | 22.76 | 21.65 | 1.612 times |
My analysis of stock is bearish for shortterm, and stock might move down till 23.1 or till 21.8. Use a stoploss of 24.15 and if the stock hits stoploss, then it can shoot up till 25.2
Share price targets for Arrowhead Pharmaceuticals (ARWR)
| Target Type | Value |
| Downside Target | 21.39 |
| Downside Target | 23.41 |
| Upside Target | 24.37 |
| Upside Target | 25.24 |
| Upside Target | 26.09 |
| Upside Target | 27.00 |
| Upside Target | 28.50 |
| Upside Target | 28.51 |
| Upside Target | 29.65 |
| Upside Target | 35.36 |
| Upside Target | 36.72 |
| Upside Target | 39.83 |
Intraday share price targets for Arrowhead Pharmaceuticals (ARWR)
| Target Type | Value |
| Downside Intraday Target | 23.1 |
| Downside Intraday Target | 22.28 |
| Upside Intraday Target | 25.05 |
| Upside Intraday Target | 26.18 |
| Upside Intraday Target | 24.23 |
Weekly technical analysis of Arrowhead Pharmaceuticals (ARWR)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 28 Tue May 2024 | 23.92 | 25.36 | 25.36 | 23.41 | 0.391 times |
| 23 Thu May 2024 | 24.67 | 24.78 | 26.09 | 24.37 | 0.339 times |
| 17 Fri May 2024 | 24.77 | 22.34 | 25.64 | 21.65 | 1.296 times |
| 10 Fri May 2024 | 22.08 | 24.56 | 25.48 | 21.79 | 1.201 times |
| 03 Fri May 2024 | 24.44 | 22.38 | 25.24 | 22.15 | 1.062 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arrowhead Pharmaceuticals (ARWR)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 28 Tue May 2024 | 23.92 | 22.72 | 26.09 | 21.65 | 0.957 times |
| 30 Tue Apr 2024 | 22.62 | 28.25 | 28.51 | 21.39 | 0.748 times |
| 28 Thu Mar 2024 | 28.60 | 32.36 | 36.72 | 27.00 | 0.774 times |
| 29 Thu Feb 2024 | 32.10 | 32.25 | 35.36 | 28.50 | 0.809 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arrowhead Pharmaceuticals (ARWR)
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arrowhead Pharmaceuticals in short term but the buy signal is initial and weak.
Arrowhead Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 23.92 and Arrowhead Pharmaceuticals (ARWR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arrowhead Pharmaceuticals in short term but the buy signal is initial and weak.
Arrowhead Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 23.92 and Arrowhead Pharmaceuticals (ARWR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.